TXMD
TherapeuticsMD, Inc.Company Information
- Company Name
- TherapeuticsMD, Inc.
- CIK
- CIK0000025743
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- TXMD: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- TXMD
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-12-23
- Last sale
- 2023-12-07
- Shares purchased (TTM)
- 10,382
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 3,651,616
- Shares outstanding
- 11,574,000
- Ownership
- 31.55%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- 6.76%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-06-30 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | - | 8 | - | 7 | 6 | 6 | 5 | 5 | 4 | - | ||||||
| Cash | - | - | - | - | - | - | - | - | 4 | 10 | ||||||
Assets Current | ||||||||||||||||
| Assets Current | 16 | 15 | 14 | 15 | 13 | 13 | 12 | 12 | 12 | 17 | ||||||
| Cash Equivalents At Carrying Value | 9 | 8 | 7 | - | - | - | 5 | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Property Plant And Equipment Net | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 6 | 7 | ||||||
| Operating Lease Right Of Use Asset | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 38 | 38 | 38 | 39 | 39 | 38 | 39 | 40 | 43 | 50 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Other Liabilities Current | - | - | - | - | - | - | - | - | - | 7 | ||||||
Liabilities Current | ||||||||||||||||
| Liabilities Current | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 7 | 15 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | - | - | - | - | - | - | - | 3 | 3 | - | ||||||
| Accrued Liabilities And Other Liabilities | 2 | 2 | 2 | 2 | 2 | 2 | 2 | - | 3 | - | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 7 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Noncurrent | - | - | - | - | - | - | - | 6 | 7 | - | ||||||
| Operating Lease Liability Noncurrent | 5 | 5 | 5 | 5 | 6 | 6 | 6 | - | 7 | 7 | ||||||
| Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 10 | 11 | 11 | 11 | 11 | 11 | 11 | 12 | 14 | 22 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||
| Additional Paid In Capital Common Stock | 979 | 979 | 979 | 979 | 979 | 979 | 979 | 979 | 979 | 977 | ||||||
| Stockholders Equity | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 28 | 29 | 28 | ||||||
| Retained Earnings Accumulated Deficit | -952 | -952 | -952 | -952 | -952 | -952 | -952 | -951 | -950 | -949 | ||||||
| Liabilities And Stockholders Equity | 38 | 38 | 38 | 39 | 39 | 38 | 39 | 40 | 43 | 50 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 640 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 12 | 32 | ||||||
| Common Stock Shares Issued | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | ||||||
| Shares Outstanding | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTherapeuticsMD, Inc. (TXMD) — SEC Financial Statements & Analysis
TherapeuticsMD, Inc. (TXMD) is a pharmaceutical preparations company, incorporated in NV. TherapeuticsMD, Inc. trades on Nasdaq as: TXMD. TherapeuticsMD, Inc. (TXMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, TherapeuticsMD, Inc. carries a market cap of $25.58M, a P/E ratio of -117.87x, a P/B ratio of 0.94x, a P/S ratio of 7.82x, an enterprise value of $16.39M, and an EV/EBITDA multiple of -4.59x. On profitability, it posts a gross margin of 100.00%, an operating margin of -120.89%, a net margin of -6.64%, a Return on Equity (ROE) of -0.80%, a Return on Assets (ROA) of -0.57%, and a Return on Invested Capital (ROIC) of -20.14%. Per share, it reports EPS of $-0.02, diluted EPS of $-0.02, free cash flow per share of $0.27, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 107.09% year-over-year, net income growth of -81.80% year-over-year, and EPS growth of -81.80% year-over-year. On the balance sheet, it maintains a current ratio of 3.22x, a quick ratio of 2.52x, working capital of $11.12M, a debt-to-equity ratio of 0.38x, a debt ratio of 0.28, an interest coverage ratio of -1317.67x, free cash flow of $3.10M (TTM), and net debt of $-9.19M. Figures sourced from SEC EDGAR.
- Market Cap
- $25.58M
- P/E TTM
- -117.87x
- EPS TTM
- $-0.02
- P/B TTM
- 0.94x
- ROE TTM
- -0.80%
- ROA TTM
- -0.57%
- Debt To Equity
- 0.38x
- Free Cash Flow TTM
- $3.10M
- Net Revenue TTM Growth 1Y
- 107.09%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is TherapeuticsMD, Inc. in?
TherapeuticsMD, Inc. (TXMD) operates in the Pharmaceutical Preparations industry.
What exchange does TXMD trade on?
TherapeuticsMD, Inc. (TXMD) trades on the Nasdaq.
Where is TherapeuticsMD, Inc. incorporated?
TherapeuticsMD, Inc. is incorporated in NV.
When was TherapeuticsMD, Inc. (TXMD)'s most recent SEC filing?
TherapeuticsMD, Inc. (TXMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is TXMD's market cap?
TherapeuticsMD, Inc. (TXMD) has a market capitalization of $25.58M as of 2026-06-30.
What is TXMD's EPS (earnings per share)?
TherapeuticsMD, Inc. (TXMD)'s trailing twelve month EPS is $-0.02 as of 2026-06-30.
What is TXMD's ROE (return on equity)?
TherapeuticsMD, Inc. (TXMD)'s trailing twelve month Return on Equity (ROE) is -0.80% as of 2026-06-30.
What is TXMD's ROA (return on assets)?
TherapeuticsMD, Inc. (TXMD)'s trailing twelve month Return on Assets (ROA) is -0.57% as of 2026-06-30.
What is TXMD's ROIC (return on invested capital)?
TherapeuticsMD, Inc. (TXMD)'s trailing twelve month Return on Invested Capital (ROIC) is -20.14% as of 2026-06-30.
What is TXMD's EV/EBITDA?
TherapeuticsMD, Inc. (TXMD)'s trailing twelve month EV/EBITDA is -4.59x as of 2026-06-30.